• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性阿尔茨海默病病例中的α-突触核蛋白阳性结构:形态及其与tau蛋白聚集的关系。

Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.

作者信息

Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, Katayama Y

机构信息

The Second Department of Internal Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, 113-8602, Tokyo, Japan.

出版信息

Brain Res. 2001 Jan 12;888(2):287-296. doi: 10.1016/s0006-8993(00)03082-1.

DOI:10.1016/s0006-8993(00)03082-1
PMID:11150486
Abstract

Alzheimer's disease (AD) and Parkinson's disease share common clinical and pathological features. In this study, we examined the relationship between AD pathology and alpha-synuclein aggregation. The frequency and distribution of alpha-synuclein-positive structures were systematically investigated in 27 cases with sporadic AD by alpha-synuclein immuno-histochemistry. Thirteen (48.2%) of 27 cases had various alpha-synuclein-positive structures as well as Lewy bodies. The frequency and density of senile plaques and neurofibrillary tangles were not significantly different between cases with alpha-synuclein structures and those without. alpha-Synuclein-positive structures were found most frequently in the amygdala. The alpha-synuclein-positive inclusions that are different from Lewy bodies were observed at the highest rate in the hippocampus. The discovery of alpha-synuclein as the constituent of Lewy bodies facilitated the detection of Lewy-related structures even in AD cases with widespread and numerous neurofibrillary tangles. alpha-Synuclein-positive inclusions except for Lewy bodies are exposed, and the distribution of them indicates that Lewy body formation may be influenced by the degree of tau aggregation. This study also supports the suggestion that cases with AD pathology can be classified into two groups according to the existence or absence of alpha-synuclein aggregation.

摘要

阿尔茨海默病(AD)和帕金森病具有共同的临床和病理特征。在本研究中,我们研究了AD病理学与α-突触核蛋白聚集之间的关系。通过α-突触核蛋白免疫组织化学方法,对27例散发性AD患者的α-突触核蛋白阳性结构的频率和分布进行了系统研究。27例患者中有13例(48.2%)既有各种α-突触核蛋白阳性结构,也有路易小体。有α-突触核蛋白结构的病例与无该结构的病例相比,老年斑和神经原纤维缠结的频率和密度无显著差异。α-突触核蛋白阳性结构最常见于杏仁核。在海马中观察到与路易小体不同的α-突触核蛋白阳性包涵体的比例最高。α-突触核蛋白作为路易小体的组成成分被发现,这使得即使在有广泛且大量神经原纤维缠结的AD病例中,也能检测到与路易小体相关的结构。除路易小体外的α-突触核蛋白阳性包涵体被发现,其分布表明路易小体的形成可能受tau蛋白聚集程度的影响。本研究还支持这样的观点,即根据α-突触核蛋白聚集的有无,AD病理学病例可分为两组。

相似文献

1
Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.散发性阿尔茨海默病病例中的α-突触核蛋白阳性结构:形态及其与tau蛋白聚集的关系。
Brain Res. 2001 Jan 12;888(2):287-296. doi: 10.1016/s0006-8993(00)03082-1.
2
Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification.与伴有钙化的弥漫性神经原纤维缠结相关的α-突触核蛋白阳性结构。
Neuropathol Appl Neurobiol. 2003 Jun;29(3):280-7. doi: 10.1046/j.1365-2990.2003.00470.x.
3
Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.帕金森病和阿尔茨海默病大脑中的α-突触核蛋白病理学:发病率和拓扑分布——一项初步研究。
Acta Neuropathol. 2003 Sep;106(3):191-201. doi: 10.1007/s00401-003-0725-y. Epub 2003 Jul 5.
4
Alpha-synuclein inclusions in Alzheimer and Lewy body diseases.阿尔茨海默病和路易体病中的α-突触核蛋白包涵体。
J Neuropathol Exp Neurol. 2000 May;59(5):408-17. doi: 10.1093/jnen/59.5.408.
5
NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).弥漫性神经原纤维缠结伴钙化(DNTC)中的NACP/α-突触核蛋白免疫反应性。
Acta Neuropathol. 2002 Oct;104(4):333-41. doi: 10.1007/s00401-002-0545-5. Epub 2002 May 8.
6
Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.嗅球中的tau病理与Braak分期、路易体病理和载脂蛋白ε4相关。
Neuropathol Appl Neurobiol. 2003 Oct;29(5):503-10. doi: 10.1046/j.1365-2990.2003.00453.x.
7
Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.阿尔茨海默病淀粉样蛋白(NAC)的非Aβ成分再探讨。NAC与α-突触核蛋白均与Aβ淀粉样蛋白无关。
Am J Pathol. 1999 Oct;155(4):1173-81. doi: 10.1016/s0002-9440(10)65220-0.
8
Lewy body pathology in Alzheimer's disease.阿尔茨海默病中的路易体病理改变。
J Mol Neurosci. 2001 Oct;17(2):225-32. doi: 10.1385/jmn:17:2:225.
9
Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.帕金森病和路易体痴呆中活性磷酸化依赖性丝裂原活化蛋白激酶(MAPK/ERK)、应激激活蛋白激酶/c-Jun氨基末端激酶(SAPK/JNK)和p38激酶的表达
J Neural Transm (Vienna). 2001;108(12):1383-96. doi: 10.1007/s007020100015.
10
Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.路易体痴呆症患者大脑中CD200和细胞间黏附分子-1(ICAM-1)水平的变化与阿尔茨海默病病理改变的程度相关,而非与α-突触核蛋白病理改变相关。
Neurobiol Aging. 2017 Jun;54:175-186. doi: 10.1016/j.neurobiolaging.2017.03.007. Epub 2017 Mar 16.

引用本文的文献

1
Evidence of a novel α-synuclein strain isolated from a Parkinson's disease with dementia patient sample.从一名帕金森病合并痴呆患者样本中分离出新型α-突触核蛋白毒株的证据。
Acta Neuropathol Commun. 2025 Aug 18;13(1):177. doi: 10.1186/s40478-025-02093-x.
2
Amyloid-β modulates the phase separation and aggregation of α-synuclein.淀粉样β蛋白调节α-突触核蛋白的相分离和聚集。
Proc Natl Acad Sci U S A. 2025 Jul 22;122(29):e2501987122. doi: 10.1073/pnas.2501987122. Epub 2025 Jul 14.
3
A hypothesis explaining Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies overlap.
一种解释阿尔茨海默病、帕金森病和路易体痴呆症重叠现象的假说。
Alzheimers Dement. 2025 Jun;21(6):e70363. doi: 10.1002/alz.70363.
4
Microglia-driven inflammation induces progressive tauopathies and synucleinopathies.小胶质细胞驱动的炎症会诱发进行性tau蛋白病和α-突触核蛋白病。
Exp Mol Med. 2025 May 1. doi: 10.1038/s12276-025-01450-z.
5
Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers.阿尔茨海默病神经病理学及其通过体液和影像生物标志物进行的评估。
Mol Neurodegener. 2025 Mar 14;20(1):33. doi: 10.1186/s13024-025-00819-y.
6
Structure-Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1-indoles as Tauopathy Positron Emission Tomography Radiotracers.2-(杂芳基-环烷基)-1-吲哚作为tau蛋白病正电子发射断层显像剂的构效关系及评价
J Med Chem. 2025 Mar 27;68(6):6462-6492. doi: 10.1021/acs.jmedchem.4c02988. Epub 2025 Mar 11.
7
Role of tau versus TDP-43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease.tau蛋白与TDP-43病理学在衰老和阿尔茨海默病中对内侧颞叶萎缩的作用
Alzheimers Dement. 2025 Feb;21(2):e14582. doi: 10.1002/alz.14582.
8
Cholesterol-mediated Lysosomal Dysfunction in Astrocytes Promotes α-Synuclein Pathology in Human Brain Tissue.胆固醇介导的星形胶质细胞溶酶体功能障碍促进人脑组织中的α-突触核蛋白病理改变。
bioRxiv. 2025 Feb 14:2025.02.09.637107. doi: 10.1101/2025.02.09.637107.
9
Influence of alpha-synuclein on glucose metabolism in Alzheimer's disease continuum: Analyses of α-synuclein seed amplification assay and FDG-PET.α-突触核蛋白对阿尔茨海默病连续体中葡萄糖代谢的影响:α-突触核蛋白种子扩增试验和氟代脱氧葡萄糖正电子发射断层扫描分析
Alzheimers Dement. 2025 Feb;21(2):e14571. doi: 10.1002/alz.14571.
10
Distinct CSF α-synuclein aggregation profiles associated with Alzheimer's disease phenotypes and MCI-to-AD conversion.与阿尔茨海默病表型及轻度认知障碍向阿尔茨海默病转化相关的不同脑脊液α-突触核蛋白聚集谱。
J Prev Alzheimers Dis. 2025 Feb;12(2):100040. doi: 10.1016/j.tjpad.2024.100040. Epub 2025 Jan 3.